Coronary Drug-Coated Balloon Catheter Market Size, Share & Trends Analysis Report By Indication (In-Stent Restenosis, De-novo Coronary Lesions), By Drug Type (Paclitaxel, Sirolimus), By End Use (Hospitals, Specialty Cardiac/Vascular Centers), By Region, And Segment Forecasts, 2026 - 2033
The global coronary drug-coated balloon catheter market size was valued at USD 342.4 million in 2025 and is projected to grow from USD 374.9 million in 2026 to USD 727.2 million by 2033, at a CAGR of 9.9% from 2026 to 2033. North America dominated the market, accounting for a share of 44.1% in 2025. Increasing Percutaneous Coronary Intervention (PCI) volumes globally are driving the demand for coronary drug-coated balloon catheters, particularly for treating in-stent restenosis and complex coronary lesions.
In addition, comprehensive reimbursement coverage for coronary interventions in countries such as the U.S., Germany, and Japan is improving patient access and accelerating the adoption of drug-coated balloon technologies.
Market Dynamic
The rising prevalence of coronary artery disease (CAD), increasing volumes of PCI procedures, and growing adoption of minimally invasive coronary revascularization techniques are driving the growth of the coronary drug-coated balloon catheter market. Increasing incidences of in-stent restenosis (ISR), small vessel disease, and complex coronary lesions are accelerating the demand for an effective alternative to repeat stenting. Continuous advancements in drug-coating technologies, particularly the development of next-generation sirolimus-coated balloons, along with expanding clinical evidence and favorable regulatory approvals, are further supporting market adoption.
However, stringent regulatory approval requirements, extensive clinical trial obligations, and the high cost of advanced interventional procedures continue to restrain market growth. Expanding commercialization of innovative technologies, increasing physician preference for "leave nothing behind" treatment strategies, and growing adoption across emerging healthcare markets are expected to create significant growth opportunities during the forecast period.
This report forecasts revenue growth at global, regional, & country levels, and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global coronary drug-coated balloon catheter market report on the basis of indication, drug type, end use, and region:
In addition, comprehensive reimbursement coverage for coronary interventions in countries such as the U.S., Germany, and Japan is improving patient access and accelerating the adoption of drug-coated balloon technologies.
Market Dynamic
The rising prevalence of coronary artery disease (CAD), increasing volumes of PCI procedures, and growing adoption of minimally invasive coronary revascularization techniques are driving the growth of the coronary drug-coated balloon catheter market. Increasing incidences of in-stent restenosis (ISR), small vessel disease, and complex coronary lesions are accelerating the demand for an effective alternative to repeat stenting. Continuous advancements in drug-coating technologies, particularly the development of next-generation sirolimus-coated balloons, along with expanding clinical evidence and favorable regulatory approvals, are further supporting market adoption.
However, stringent regulatory approval requirements, extensive clinical trial obligations, and the high cost of advanced interventional procedures continue to restrain market growth. Expanding commercialization of innovative technologies, increasing physician preference for "leave nothing behind" treatment strategies, and growing adoption across emerging healthcare markets are expected to create significant growth opportunities during the forecast period.
Global Coronary Drug-Coated Balloon Catheter Market Report Segmentation
This report forecasts revenue growth at global, regional, & country levels, and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global coronary drug-coated balloon catheter market report on the basis of indication, drug type, end use, and region:
- Indication Outlook (Revenue, USD Million, 2021 - 2033)
- In-Stent Restenosis (ISR)
- De-novo coronary lesions
- Complex / Adjunct Coronary Lesions
- Drug Type Outlook (Revenue, USD Million, 2021 - 2033)
- Paclitaxel
- Sirolimus
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Specialty Cardiac/Vascular Centers
- Ambulatory Surgical Centers (ASCs)
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- Australia
- India
- South Korea
- Thailand
- Indonesia
- Malaysia
- Vietnam
- Latin America
- Brazil
- Argentina
- Colombia
- Chile
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Indication
1.1.2. Drug Type
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Indication outlook
2.2.2. Drug type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. CORONARY DRUG-COATED BALLOON CATHETERS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.2.4. Market challenge analysis
3.3. Coronary Drug-Coated Balloon Catheters Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Legal landscape
3.3.2.6. Environmental landscape
3.4. Country-Level Market Driver Mapping (Coronary DCB)
3.4.1. Regulatory Landscape Influencing the Coronary Drug-Coated Balloon Market Dynamics
3.4.2. Clinical Trial Presence in Major Countries
3.4.3. Global Distribution Footprint
3.4.4. Pricing Competitiveness
3.5. Innovation & Product Development Analysis
3.5.1. New Product Launches
3.5.2. Product Pipeline
3.5.3. Emerging Coating Technologies
3.6. Market Entry Attractiveness Assessment
CHAPTER 4. CORONARY DRUG-COATED BALLOON CATHETERS MARKET: INDICATION ESTIMATES & TREND ANALYSIS
4.1. Definition and Scope
4.2. Indication Market Share, 2025 & 2033
4.3. Segment Dashboard
4.4. Coronary Drug-Coated Balloon Catheters Market by Indication Area Outlook
4.5. In-Stent Restenosis (ISR)
4.5.1. In-stent restenosis (ISR) market estimates and forecast, 2021 to 2033 (USD Million)
4.6. De-novo Coronary Lesions
4.6.1. De-novo coronary lesions market estimates and forecast, 2021 to 2033 (USD Million)
4.7. Complex / Adjunct Coronary Lesions
4.7.1. Complex / adjunct coronary lesions market estimates and forecast, 2021 to 2033 (USD Million)
CHAPTER 5. CORONARY DRUG-COATED BALLOON CATHETERS MARKET: TECHNOLOGY INTEGRATION ESTIMATES & TREND ANALYSIS
5.1. Definition and Scope
5.2. Drug Type Market Share, 2025 & 2033
5.3. Segment Dashboard
5.4. Coronary Drug-Coated Balloon Catheters Market by Drug Type Outlook
5.5. Paclitaxel
5.5.1. Paclitaxel market estimates and forecast, 2021 to 2033 (USD Million)
5.6. Sirolimus
5.6.1. Sirolimus market estimates and forecast, 2021 to 2033 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecast, 2021 to 2033 (USD Million)
CHAPTER 6. CORONARY DRUG-COATED BALLOON CATHETERS MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Definition and Scope
6.2. End Use Market Share, 2025 & 2033
6.3. Segment Dashboard
6.4. Coronary Drug-Coated Balloon Catheters Market by End Use Outlook
6.5. E- Hospitals
6.5.1. Hospitals market estimates and forecast, 2021 to 2033 (USD Million)
6.6. Specialty Cardiac/Vascular Centers
6.6.1. Specialty cardiac/vascular centers market estimates and forecast, 2021 to 2033 (USD Million)
6.7. Ambulatory Surgical Centers (ASCs)
6.7.1. Ambulatory surgical centers (ASCs) market estimates and forecast, 2021 to 2033 (USD Million)
CHAPTER 7. CORONARY DRUG-COATED BALLOON CATHETERS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY INDICATION, BY DRUG TYPE, BY END USE
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Competitive scenario
7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.4.1.5. U.S. market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.4.2.5. Canada market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.4.3.5. Mexico market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.5.1.5. UK market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2.5. Germany market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
7.5.3.5. France market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.5.4.5. Italy market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
7.5.5.5. Spain market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.5.6.5. Norway market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
7.5.7.5. Sweden market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.5.8.5. Denmark market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.6.1.5. Japan market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2.5. China market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
7.6.3.5. India market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.4.5. Australia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.6.5.5. South Korea market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.6.6.5. Thailand market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.7. Indonesia
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive scenario
7.6.7.4. Indonesia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.7.5. Indonesia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.8. Malaysia
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework
7.6.8.3. Competitive scenario
7.6.8.4. Malaysia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.8.5. Malaysia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.9. Vietnam
7.6.9.1. Key country dynamics
7.6.9.2. Regulatory framework
7.6.9.3. Competitive scenario
7.6.9.4. Vietnam market estimates and forecasts 2021 to 2033 (USD Million)
7.6.9.5. Vietnam market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.7.1.5. Brazil market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2.5. Argentina market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.7.3. Colombia
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive scenario
7.7.3.4. Colombia market estimates and forecasts 2021 to 2033 (USD Million)
7.7.3.5. Colombia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.7.4. Chile
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework
7.7.4.3. Competitive scenario
7.7.4.4. Chile market estimates and forecasts 2021 to 2033 (USD Million)
7.7.4.5. Chile market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive scenario
7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.8.1.5. South Africa market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2.5. Saudi Arabia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.8.3.5. UAE market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
7.8.4.5. Kuwait market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key Company Market Share Analysis, 2025 (%)
8.4. List of Companies
8.4.1. Boston Scientific
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Lepu Medical
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Medtronic
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. B. Braun SE
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Concept Medical
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Teleflex Incorporated (BIOTRONIK)
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. MicroPort Scientific Corporation
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. iVascular S.L.U.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. Indication
1.1.2. Drug Type
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Indication outlook
2.2.2. Drug type outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. CORONARY DRUG-COATED BALLOON CATHETERS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.2.4. Market challenge analysis
3.3. Coronary Drug-Coated Balloon Catheters Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Legal landscape
3.3.2.6. Environmental landscape
3.4. Country-Level Market Driver Mapping (Coronary DCB)
3.4.1. Regulatory Landscape Influencing the Coronary Drug-Coated Balloon Market Dynamics
3.4.2. Clinical Trial Presence in Major Countries
3.4.3. Global Distribution Footprint
3.4.4. Pricing Competitiveness
3.5. Innovation & Product Development Analysis
3.5.1. New Product Launches
3.5.2. Product Pipeline
3.5.3. Emerging Coating Technologies
3.6. Market Entry Attractiveness Assessment
CHAPTER 4. CORONARY DRUG-COATED BALLOON CATHETERS MARKET: INDICATION ESTIMATES & TREND ANALYSIS
4.1. Definition and Scope
4.2. Indication Market Share, 2025 & 2033
4.3. Segment Dashboard
4.4. Coronary Drug-Coated Balloon Catheters Market by Indication Area Outlook
4.5. In-Stent Restenosis (ISR)
4.5.1. In-stent restenosis (ISR) market estimates and forecast, 2021 to 2033 (USD Million)
4.6. De-novo Coronary Lesions
4.6.1. De-novo coronary lesions market estimates and forecast, 2021 to 2033 (USD Million)
4.7. Complex / Adjunct Coronary Lesions
4.7.1. Complex / adjunct coronary lesions market estimates and forecast, 2021 to 2033 (USD Million)
CHAPTER 5. CORONARY DRUG-COATED BALLOON CATHETERS MARKET: TECHNOLOGY INTEGRATION ESTIMATES & TREND ANALYSIS
5.1. Definition and Scope
5.2. Drug Type Market Share, 2025 & 2033
5.3. Segment Dashboard
5.4. Coronary Drug-Coated Balloon Catheters Market by Drug Type Outlook
5.5. Paclitaxel
5.5.1. Paclitaxel market estimates and forecast, 2021 to 2033 (USD Million)
5.6. Sirolimus
5.6.1. Sirolimus market estimates and forecast, 2021 to 2033 (USD Million)
5.7. Others
5.7.1. Others market estimates and forecast, 2021 to 2033 (USD Million)
CHAPTER 6. CORONARY DRUG-COATED BALLOON CATHETERS MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Definition and Scope
6.2. End Use Market Share, 2025 & 2033
6.3. Segment Dashboard
6.4. Coronary Drug-Coated Balloon Catheters Market by End Use Outlook
6.5. E- Hospitals
6.5.1. Hospitals market estimates and forecast, 2021 to 2033 (USD Million)
6.6. Specialty Cardiac/Vascular Centers
6.6.1. Specialty cardiac/vascular centers market estimates and forecast, 2021 to 2033 (USD Million)
6.7. Ambulatory Surgical Centers (ASCs)
6.7.1. Ambulatory surgical centers (ASCs) market estimates and forecast, 2021 to 2033 (USD Million)
CHAPTER 7. CORONARY DRUG-COATED BALLOON CATHETERS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY INDICATION, BY DRUG TYPE, BY END USE
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. North America
7.4.1. U.S.
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework
7.4.1.3. Competitive scenario
7.4.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
7.4.1.5. U.S. market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.4.2. Canada
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive scenario
7.4.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
7.4.2.5. Canada market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.4.3. Mexico
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive scenario
7.4.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.4.3.5. Mexico market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5. Europe
7.5.1. UK
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework
7.5.1.3. Competitive scenario
7.5.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
7.5.1.5. UK market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.2. Germany
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive scenario
7.5.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2.5. Germany market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.3. France
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive scenario
7.5.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
7.5.3.5. France market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.4. Italy
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework
7.5.4.3. Competitive scenario
7.5.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
7.5.4.5. Italy market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.5. Spain
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework
7.5.5.3. Competitive scenario
7.5.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
7.5.5.5. Spain market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.6. Norway
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework
7.5.6.3. Competitive scenario
7.5.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
7.5.6.5. Norway market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.7. Sweden
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework
7.5.7.3. Competitive scenario
7.5.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
7.5.7.5. Sweden market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.5.8. Denmark
7.5.8.1. Key country dynamics
7.5.8.2. Regulatory framework
7.5.8.3. Competitive scenario
7.5.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.5.8.5. Denmark market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6. Asia Pacific
7.6.1. Japan
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework
7.6.1.3. Competitive scenario
7.6.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
7.6.1.5. Japan market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.2. China
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive scenario
7.6.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2.5. China market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.3. India
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive scenario
7.6.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
7.6.3.5. India market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.4. Australia
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive scenario
7.6.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.4.5. Australia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.5. South Korea
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive scenario
7.6.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
7.6.5.5. South Korea market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.6. Thailand
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework
7.6.6.3. Competitive scenario
7.6.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.6.6.5. Thailand market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.7. Indonesia
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework
7.6.7.3. Competitive scenario
7.6.7.4. Indonesia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.7.5. Indonesia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.8. Malaysia
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework
7.6.8.3. Competitive scenario
7.6.8.4. Malaysia market estimates and forecasts 2021 to 2033 (USD Million)
7.6.8.5. Malaysia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.6.9. Vietnam
7.6.9.1. Key country dynamics
7.6.9.2. Regulatory framework
7.6.9.3. Competitive scenario
7.6.9.4. Vietnam market estimates and forecasts 2021 to 2033 (USD Million)
7.6.9.5. Vietnam market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.7. Latin America
7.7.1. Brazil
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework
7.7.1.3. Competitive scenario
7.7.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
7.7.1.5. Brazil market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.7.2. Argentina
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework
7.7.2.3. Competitive scenario
7.7.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2.5. Argentina market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.7.3. Colombia
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework
7.7.3.3. Competitive scenario
7.7.3.4. Colombia market estimates and forecasts 2021 to 2033 (USD Million)
7.7.3.5. Colombia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.7.4. Chile
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework
7.7.4.3. Competitive scenario
7.7.4.4. Chile market estimates and forecasts 2021 to 2033 (USD Million)
7.7.4.5. Chile market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.8. MEA
7.8.1. South Africa
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework
7.8.1.3. Competitive scenario
7.8.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
7.8.1.5. South Africa market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.8.2. Saudi Arabia
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework
7.8.2.3. Competitive scenario
7.8.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2.5. Saudi Arabia market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.8.3. UAE
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework
7.8.3.3. Competitive scenario
7.8.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
7.8.3.5. UAE market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
7.8.4. Kuwait
7.8.4.1. Key country dynamics
7.8.4.2. Regulatory framework
7.8.4.3. Competitive scenario
7.8.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
7.8.4.5. Kuwait market volume estimates and forecasts 2021 to 2033 (Unit Volume, 000’ Units)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key Company Market Share Analysis, 2025 (%)
8.4. List of Companies
8.4.1. Boston Scientific
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Lepu Medical
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Medtronic
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. B. Braun SE
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Concept Medical
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. Teleflex Incorporated (BIOTRONIK)
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. MicroPort Scientific Corporation
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. iVascular S.L.U.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 4 North America coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 5 North America coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 6 North America coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
Table 7 U.S. coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 8 U.S. coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 9 U.S. coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 10 Canada coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 11 Canada coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 12 Canada coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 13 Mexico coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 14 Mexico coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 15 Mexico coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 16 Europe coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 17 Europe coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 18 Europe coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 19 Europe coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
Table 20 UK coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 21 UK coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 22 UK coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 23 Germany coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 24 Germany coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 25 Germany coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 26 France coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 27 France coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 28 France coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 29 Italy coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 30 Italy coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 31 Italy coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 32 Spain coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 33 Spain coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 34 Spain coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 35 Denmark coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 36 Denmark coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 37 Denmark coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 38 Sweden coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 39 Sweden coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 40 Sweden coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 41 Norway coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 42 Norway coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 43 Norway coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 44 Asia Pacific coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 45 Asia Pacific coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 46 Asia Pacific coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 47 Asia Pacific coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
Table 48 China coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 49 China coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 50 China coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 51 Japan coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 52 Japan coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 53 Japan coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 54 India coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 55 India coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 56 India coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 57 Australia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 58 Australia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 59 Australia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 60 South Korea coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 61 South Korea coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 62 South Korea coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 63 Thailand coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 64 Thailand coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 65 Thailand coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 66 Indonesia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 67 Indonesia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 68 Indonesia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 69 Malaysia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 70 Malaysia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 71 Malaysia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 72 Vietnam coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 73 Vietnam coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 74 Vietnam coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 75 Latin America coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 76 Latin America coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 77 Latin America coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 78 Latin America coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
Table 79 Brazil coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 80 Brazil coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 81 Brazil coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 82 Argentina coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 83 Argentina coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 84 Argentina coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 85 Colombia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 86 Colombia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 87 Colombia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 88 Chile coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 89 Chile coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 90 Chile coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 91 MEA coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 92 MEA coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 93 MEA coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 94 MEA coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
Table 95 South Africa coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 96 South Africa coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 97 South Africa coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 98 Saudi Arabia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 99 Saudi Arabia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 100 Saudi Arabia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 101 UAE coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 102 UAE coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 103 UAE coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 104 Kuwait coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 105 Kuwait coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 106 Kuwait coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 4 North America coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 5 North America coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 6 North America coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
Table 7 U.S. coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 8 U.S. coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 9 U.S. coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 10 Canada coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 11 Canada coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 12 Canada coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 13 Mexico coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 14 Mexico coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 15 Mexico coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 16 Europe coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 17 Europe coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 18 Europe coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 19 Europe coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
Table 20 UK coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 21 UK coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 22 UK coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 23 Germany coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 24 Germany coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 25 Germany coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 26 France coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 27 France coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 28 France coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 29 Italy coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 30 Italy coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 31 Italy coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 32 Spain coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 33 Spain coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 34 Spain coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 35 Denmark coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 36 Denmark coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 37 Denmark coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 38 Sweden coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 39 Sweden coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 40 Sweden coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 41 Norway coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 42 Norway coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 43 Norway coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 44 Asia Pacific coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 45 Asia Pacific coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 46 Asia Pacific coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 47 Asia Pacific coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
Table 48 China coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 49 China coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 50 China coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 51 Japan coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 52 Japan coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 53 Japan coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 54 India coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 55 India coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 56 India coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 57 Australia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 58 Australia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 59 Australia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 60 South Korea coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 61 South Korea coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 62 South Korea coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 63 Thailand coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 64 Thailand coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 65 Thailand coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 66 Indonesia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 67 Indonesia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 68 Indonesia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 69 Malaysia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 70 Malaysia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 71 Malaysia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 72 Vietnam coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 73 Vietnam coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 74 Vietnam coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 75 Latin America coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 76 Latin America coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 77 Latin America coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 78 Latin America coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
Table 79 Brazil coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 80 Brazil coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 81 Brazil coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 82 Argentina coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 83 Argentina coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 84 Argentina coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 85 Colombia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 86 Colombia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 87 Colombia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 88 Chile coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 89 Chile coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 90 Chile coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 91 MEA coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 92 MEA coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 93 MEA coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 94 MEA coronary drug-coated balloon catheter Market, by Country, 2021 - 2033 (USD Million)
Table 95 South Africa coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 96 South Africa coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 97 South Africa coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 98 Saudi Arabia coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 99 Saudi Arabia coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 100 Saudi Arabia coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 101 UAE coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 102 UAE coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 103 UAE coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
Table 104 Kuwait coronary drug-coated balloon catheter market, by Indication, 2021 - 2033 (USD Million)
Table 105 Kuwait coronary drug-coated balloon catheter market, by Drug type, 2021 - 2033 (USD Million)
Table 106 Kuwait coronary drug-coated balloon catheter market, by End use, 2021 - 2033 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Coronary drug-coated balloon catheter: Market outlook
Fig. 9 Coronary drug-coated balloon catheter: Competitive Insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Coronary drug-coated balloon catheter market driver impact
Fig. 15 Coronary drug-coated balloon catheter market restraint impact
Fig. 16 Coronary drug-coated balloon catheter market strategic initiative
Fig. 17 Coronary drug-coated balloon catheter market: Indication movement
Fig. 18 Coronary drug-coated balloon catheter market: Indication outlook
Fig. 19 In-stent restenosis (ISR) market estimates and forecasts, 2021 - 2033
Fig. 20 De-novo coronary lesions market estimates and forecasts, 2021 - 2033
Fig. 21 Complex / adjunct coronary lesions market estimates and forecasts, 2021 - 2033
Fig. 22 Coronary drug-coated balloon catheter market: Drug type movement
Fig. 23 Coronary drug-coated balloon catheter market: Drug type outlook
Fig. 24 Paclitaxel market estimates and forecasts, 2021 - 2033
Fig. 25 Sirolimus market estimates and forecasts, 2021 - 203
Fig. 26 Others market estimates and forecasts, 2021 - 2033
Fig. 27 Coronary drug-coated balloon catheter market: End use movement
Fig. 28 Coronary drug-coated balloon catheter market: End use outlook
Fig. 29 Hospitals market estimates and forecasts, 2021 - 2033
Fig. 30 Specialty cardiac/vascular centers market estimates and forecasts, 2021 - 203
Fig. 31 Ambulatory surgical centers (ASCs) market estimates and forecasts, 2021 - 2033
Fig. 32 Coronary drug-coated balloon catheter market: Regional
Fig. 33 Coronary drug-coated balloon catheter market: Regional
Fig. 34 North America market estimates and forecasts, 2021 - 2033
Fig. 35 US market estimates and forecasts, 2021 - 2033
Fig. 36 Canada market estimates and forecasts, 2021 - 2033
Fig. 37 Mexico market estimates and forecasts, 2021 - 2033
Fig. 38 Europe market estimates and forecasts, 2021 - 2033
Fig. 39 UK market estimates and forecasts, 2021 - 2033
Fig. 40 Germany market estimates and forecasts, 2021 - 2033
Fig. 41 France market estimates and forecasts, 2021 - 2033
Fig. 42 Italy market estimates and forecasts, 2021 - 2033
Fig. 43 Spain market estimates and forecasts, 2021 - 2033
Fig. 44 Sweden market estimates and forecasts, 2021 - 2033
Fig. 45 Norway market estimates and forecasts, 2021 - 2033
Fig. 46 Denmark market estimates and forecasts, 2021 - 2033
Fig. 47 Asia Pacific market estimates and forecasts, 2021 - 2033
Fig. 48 Japan market estimates and forecasts, 2021 - 2033
Fig. 49 China market estimates and forecasts, 2021 - 2033
Fig. 50 India market estimates and forecasts, 2021 - 2033
Fig. 51 Australia market estimates and forecasts, 2021 - 2033
Fig. 52 Thailand market estimates and forecasts, 2021 - 2033
Fig. 53 South Korea market estimates and forecasts, 2021 - 2033
Fig. 54 Indonesia market estimates and forecasts, 2021 - 2033
Fig. 55 Malaysia market estimates and forecasts, 2021 - 2033
Fig. 56 Vietnam market estimates and forecasts, 2021 - 2033
Fig. 57 Latin America market estimates and forecasts, 2021 - 2033
Fig. 58 Brazil market estimates and forecasts, 2021 - 2033
Fig. 59 Argentina market estimates and forecasts, 2021 - 2033
Fig. 60 Colombia market estimates and forecasts, 2021 - 2033
Fig. 61 Chile market estimates and forecasts, 2021 - 2033
Fig. 62 Middle East and Africa market estimates and forecasts, 2021 - 2033
Fig. 63 Saudi Arabia market estimates and forecasts, 2021 - 2033
Fig. 64 South Africa market estimates and forecasts, 2021 - 2033
Fig. 65 UAE market estimates and forecasts, 2021 - 2033
Fig. 66 Kuwait market estimates and forecasts, 2021 - 2033
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Coronary drug-coated balloon catheter: Market outlook
Fig. 9 Coronary drug-coated balloon catheter: Competitive Insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Coronary drug-coated balloon catheter market driver impact
Fig. 15 Coronary drug-coated balloon catheter market restraint impact
Fig. 16 Coronary drug-coated balloon catheter market strategic initiative
Fig. 17 Coronary drug-coated balloon catheter market: Indication movement
Fig. 18 Coronary drug-coated balloon catheter market: Indication outlook
Fig. 19 In-stent restenosis (ISR) market estimates and forecasts, 2021 - 2033
Fig. 20 De-novo coronary lesions market estimates and forecasts, 2021 - 2033
Fig. 21 Complex / adjunct coronary lesions market estimates and forecasts, 2021 - 2033
Fig. 22 Coronary drug-coated balloon catheter market: Drug type movement
Fig. 23 Coronary drug-coated balloon catheter market: Drug type outlook
Fig. 24 Paclitaxel market estimates and forecasts, 2021 - 2033
Fig. 25 Sirolimus market estimates and forecasts, 2021 - 203
Fig. 26 Others market estimates and forecasts, 2021 - 2033
Fig. 27 Coronary drug-coated balloon catheter market: End use movement
Fig. 28 Coronary drug-coated balloon catheter market: End use outlook
Fig. 29 Hospitals market estimates and forecasts, 2021 - 2033
Fig. 30 Specialty cardiac/vascular centers market estimates and forecasts, 2021 - 203
Fig. 31 Ambulatory surgical centers (ASCs) market estimates and forecasts, 2021 - 2033
Fig. 32 Coronary drug-coated balloon catheter market: Regional
Fig. 33 Coronary drug-coated balloon catheter market: Regional
Fig. 34 North America market estimates and forecasts, 2021 - 2033
Fig. 35 US market estimates and forecasts, 2021 - 2033
Fig. 36 Canada market estimates and forecasts, 2021 - 2033
Fig. 37 Mexico market estimates and forecasts, 2021 - 2033
Fig. 38 Europe market estimates and forecasts, 2021 - 2033
Fig. 39 UK market estimates and forecasts, 2021 - 2033
Fig. 40 Germany market estimates and forecasts, 2021 - 2033
Fig. 41 France market estimates and forecasts, 2021 - 2033
Fig. 42 Italy market estimates and forecasts, 2021 - 2033
Fig. 43 Spain market estimates and forecasts, 2021 - 2033
Fig. 44 Sweden market estimates and forecasts, 2021 - 2033
Fig. 45 Norway market estimates and forecasts, 2021 - 2033
Fig. 46 Denmark market estimates and forecasts, 2021 - 2033
Fig. 47 Asia Pacific market estimates and forecasts, 2021 - 2033
Fig. 48 Japan market estimates and forecasts, 2021 - 2033
Fig. 49 China market estimates and forecasts, 2021 - 2033
Fig. 50 India market estimates and forecasts, 2021 - 2033
Fig. 51 Australia market estimates and forecasts, 2021 - 2033
Fig. 52 Thailand market estimates and forecasts, 2021 - 2033
Fig. 53 South Korea market estimates and forecasts, 2021 - 2033
Fig. 54 Indonesia market estimates and forecasts, 2021 - 2033
Fig. 55 Malaysia market estimates and forecasts, 2021 - 2033
Fig. 56 Vietnam market estimates and forecasts, 2021 - 2033
Fig. 57 Latin America market estimates and forecasts, 2021 - 2033
Fig. 58 Brazil market estimates and forecasts, 2021 - 2033
Fig. 59 Argentina market estimates and forecasts, 2021 - 2033
Fig. 60 Colombia market estimates and forecasts, 2021 - 2033
Fig. 61 Chile market estimates and forecasts, 2021 - 2033
Fig. 62 Middle East and Africa market estimates and forecasts, 2021 - 2033
Fig. 63 Saudi Arabia market estimates and forecasts, 2021 - 2033
Fig. 64 South Africa market estimates and forecasts, 2021 - 2033
Fig. 65 UAE market estimates and forecasts, 2021 - 2033
Fig. 66 Kuwait market estimates and forecasts, 2021 - 2033
More Publications
Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
US$ 5,950.00
January 2025
150 pages
Osteoporosis Drugs Market Analysis By Product (Branded, Bisphosphonates, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM), Rank Ligand Inhibitors, Generics), And Segment Forecasts, 2014 - 2025
US$ 5,950.00
January 2017
78 pages
Pharmacy Market Size, Share & Trends Analysis Report By Product Type (Prescription, OTC), By Pharmacy Type (Retail, ePharmacy), By Region (North America, APAC), And Segment Forecasts, 2022 - 2028
US$ 5,950.00
January 2022
150 pages
